2.84 USD
↘ 0.03 (1.05%)AT CLOSE (11:59 AM EDT)
Compugen Ltd
CGENNASDAQ • USD
2.81
↘ 0.03 (1.06%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
2.81
↘ 0.03 (1.06%)
Market: CLOSED
Shares of Compugen Ltd (CGEN) are trading at $2.83. The technical outlook is "Strong Buy" based on moving average alignment, RSI, and MACD signals. Key drivers include a bullish Golden Cross on the moving averages and bullish moving average alignment.
Technical & fundamental data as of Aug 26, 2026.
Open?$2.83
High?$2.94
Low?$2.80
Prev. Close?$2.87
Volume?667.0K
Avg. Volume?N/A
VWAP?$2.87
Bid / Ask
Bid?$2.81 × 300
Ask?$2.89 × 400
Spread?$0.08
Midpoint?$2.85
Valuation & Ratios
Market Cap?271.9M
Shares Out?N/A
Float?93.5M
Float %?99.9%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
Themes
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestVery High
Short % of Float?3.24%Low
Short Interest?3.0M
Days to Cover?10.0
Free Float93.5M
Avg Daily Volume302.9K
Settlement Date2026-08-14